InspireMD (NSPR) Revenue Growth (3y) (2013 - 2025)
InspireMD (NSPR) Revenue Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 4.63% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 8.01% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 15.36% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 10.52% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 17.14% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.73% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.92% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | InspireMD | 2,073.45 | -54.21 Mn | 1.18 Mn | 45.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 45.33% |
| Sep 30, 2025 | 20.81% |
| Jun 30, 2025 | 5.11% |
| Mar 31, 2025 | 8.93% |
| Dec 31, 2024 | 12.20% |
| Sep 30, 2024 | 19.11% |
| Jun 30, 2024 | 18.77% |
| Mar 31, 2024 | 14.52% |
| Dec 31, 2023 | 123.37% |
| Sep 30, 2023 | 16.66% |
| Jun 30, 2023 | 74.00% |
| Mar 31, 2023 | 6.21% |
| Dec 31, 2022 | 0.43% |
| Sep 30, 2022 | 15.08% |
| Jun 30, 2022 | 4.18% |
| Mar 31, 2022 | 41.79% |
| Dec 31, 2021 | 18.85% |
| Sep 30, 2021 | 11.67% |
| Jun 30, 2021 | 1.15% |
| Mar 31, 2021 | -0.03% |